In parallel with the increasingly widespread availability of high performance imaging platforms and recent progresses in pathobiological characterisation and treatment of gastrointestinal malignancies, imaging biomarkers have become a major research topic due to their potential to provide additional quantitative information to conventional imaging modalities that can improve accuracy at staging and follow-up, predict outcome, and guide treatment planning in an individualised manner. The aim of this review is to briefly examine the status of current knowledge about imaging biomarkers in the field of upper gastrointestinal cancers, highlighting their potential applications and future perspectives in patient management from diagnosis onwards
In view of the trend towards personalized treatment strategies for (cancer) patients, there is an in...
Metabolic imaging and early response assessment by positron emission tomography (PET) are gaining im...
Utilisation of New Biomarkers for the Optimalization of Diagnostics and Therapy of Tumors of the Gas...
In parallel with the increasingly widespread availability of high performance imaging platforms and ...
INTRODUCTION: Detecting upper gastrointestinal (GI) cancers in primary care is challenging, as cance...
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used da...
Gastrointestinal cancers account for approximately 25% of all cancer deaths in the Western world. Th...
Patient with pancreatic and esophageal cancer have a dismal prognosis and treatment response varies ...
In the new era of precision medicine, increasing knowledge of the underlying signaling pathways and ...
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used da...
Biomarkers refer to a plethora of biological characteristics that can be quantified to facilitate ca...
Biomarkers are critically important in clinical oncology. In addition to providing valuable prognost...
The pathologist emerged in the personalized medicine era as a central actor in the definition of the...
Background and scope In the epoch of precision medicine and personalised oncology, which aims to del...
In view of the trend towards personalized treatment strategies for (cancer) patients, there is an in...
Metabolic imaging and early response assessment by positron emission tomography (PET) are gaining im...
Utilisation of New Biomarkers for the Optimalization of Diagnostics and Therapy of Tumors of the Gas...
In parallel with the increasingly widespread availability of high performance imaging platforms and ...
INTRODUCTION: Detecting upper gastrointestinal (GI) cancers in primary care is challenging, as cance...
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used da...
Gastrointestinal cancers account for approximately 25% of all cancer deaths in the Western world. Th...
Patient with pancreatic and esophageal cancer have a dismal prognosis and treatment response varies ...
In the new era of precision medicine, increasing knowledge of the underlying signaling pathways and ...
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used da...
Biomarkers refer to a plethora of biological characteristics that can be quantified to facilitate ca...
Biomarkers are critically important in clinical oncology. In addition to providing valuable prognost...
The pathologist emerged in the personalized medicine era as a central actor in the definition of the...
Background and scope In the epoch of precision medicine and personalised oncology, which aims to del...
In view of the trend towards personalized treatment strategies for (cancer) patients, there is an in...
Metabolic imaging and early response assessment by positron emission tomography (PET) are gaining im...
Utilisation of New Biomarkers for the Optimalization of Diagnostics and Therapy of Tumors of the Gas...